We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Smallpox Vaccine Effective for Monkeypox

By Biotechdaily staff writers
Posted on 23 Aug 2005
Researchers using a sensitive immunoassay to study the 2003 outbreak of monkeypox in the United States have found that while 72 cases had been reported, the actual number of individuals who contracted the disease was probably much greater, since those who had been vaccinated against smallpox did not develop symptoms of monkeypox.

Investigators at the Oregon Health & Science University (Beaverton, OR, USA) tested sera from individuals exposed to monkeypox during the 2003 Wisconsin outbreak. More...
Those who had contracted the disease, whether or not they became ill, were detected with a highly accurate enzyme-linked immunosorbent assay (ELISA) that demonstrated 95% sensitivity and 90% specificity.

Results published in the August 7, 2005, online edition of Nature Medicine indicated that the 2003 monkeypox outbreak probably extended beyond the officially recognized 72 cases. This conclusion was based on the identification of three previously unreported cases of monkeypox in individuals at 13, 29, and 48 years after smallpox vaccination. These individuals were unaware that they had been infected because they did not experience any recognizable disease symptoms.

"Our research demonstrates that the limitations of currently used technology likely allowed monkeypox cases to slip through the system. This problem was further exacerbated by the two-week delay that occurred during the diagnosis of the first monkeypox cases,” explained senior author Dr. Mark Slifka, assistant professor of molecular microbiology and immunology at Oregon Health & Science University. "If the 2003 outbreak had been smallpox instead of monkeypox, the situation could have been much worse because secondary spread of the virus to other victims would likely have occurred before the outbreak was recognized.”



Related Links:
Oregon Health & Science Univ

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Pipette Calibration System
Artel PCS®
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.